A/B TCD Peripheral Blood Stem Cell Transplantation
Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 150 patients (estimated)
- Sponsors
- University of Minnesota - Masonic Cancer Center
- Tags
- Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- 4 weeks ago
- SparkCures ID
- 1870
- NCT Identifier
- NCT05735717
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.